PL1976863T3 - Cykliczne peptydy przeciwbakteryjne - Google Patents

Cykliczne peptydy przeciwbakteryjne

Info

Publication number: PL1976863T3
Authority: PL; Poland
Prior art keywords: antimicrobial peptides; cyclic antimicrobial; cyclic; peptides; antimicrobial
Prior art date: 2005-12-22

Application number

PL06842187T

Other languages

English (en)

Inventor

Deborah O'neil

Original Assignee

Novabiotics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-22

Filing date

2006-12-21

Publication date

2013-07-31

2005-12-22 Priority claimed from GBGB0526120.1A external-priority patent/GB0526120D0/en

2006-12-21 Application filed by Novabiotics Ltd filed Critical Novabiotics Ltd

2013-07-31 Publication of PL1976863T3 publication Critical patent/PL1976863T3/pl

Links

102000044503 Antimicrobial Peptides Human genes 0.000 title 1
108700042778 Antimicrobial Peptides Proteins 0.000 title 1
125000004122 cyclic group Chemical group 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Dermatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

PL06842187T 2005-12-22 2006-12-21 Cykliczne peptydy przeciwbakteryjne PL1976863T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB0526120.1A GB0526120D0 (en)	2005-12-22	2005-12-22	Therapeutic peptides
US77650506P	2006-02-24	2006-02-24
EP06842187A EP1976863B1 (en)	2005-12-22	2006-12-21	Cyclic antimicrobial peptides
PCT/GB2006/004890 WO2007072037A1 (en)	2005-12-22	2006-12-21	Cyclic antimicrobial peptides

Publications (1)

Publication Number	Publication Date
PL1976863T3 true PL1976863T3 (pl)	2013-07-31

Family

ID=37836928

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL06842187T PL1976863T3 (pl)	2005-12-22	2006-12-21	Cykliczne peptydy przeciwbakteryjne

Country Status (15)

Country	Link
US (2)	US8324154B2 (pl)
EP (4)	EP1976863B1 (pl)
JP (3)	JP5559477B2 (pl)
KR (1)	KR101413746B1 (pl)
AU (1)	AU2006327973B2 (pl)
CA (1)	CA2655448C (pl)
CY (1)	CY1113770T1 (pl)
HK (1)	HK1121462A1 (pl)
IL (2)	IL192373A (pl)
MX (1)	MX2008008291A (pl)
NO (1)	NO346186B1 (pl)
PL (1)	PL1976863T3 (pl)
RU (1)	RU2463308C2 (pl)
WO (1)	WO2007072037A1 (pl)
ZA (1)	ZA200806329B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO346186B1 (no) *	2005-12-22	2022-04-11	Novabiotics Ltd	Anvendelse av et syklisk peptid for fremstilling av et medikament for behandling eller forebyggelse av en soppinfeksjon.
GB0702020D0 (en) *	2007-02-02	2007-03-14	Novabiotics Ltd	Peptides and their use
WO2010080819A1 (en)	2009-01-06	2010-07-15	C3 Jian, Inc.	Targeted antimicrobial moieties
WO2012135846A1 (en) *	2011-04-01	2012-10-04	Northeastern University	Methods of eradicating bacterial cell populations
CN104093734A (zh) *	2011-12-21	2014-10-08	明尼苏达大学董事会	阳离子肽和这类肽抑制外毒素产生的用途
KR101502797B1 (ko) *	2012-08-22	2015-03-17	연세대학교 산학협력단	신규한 양친매성　고리형 펩티드, 이의 제조방법 및 이를 포함하는 안정한 자기조립 나노전달체
US9082888B2 (en)	2012-10-17	2015-07-14	New York University	Inverted orthogonal spin transfer layer stack
US10815276B2 (en)	2014-05-21	2020-10-27	Entrada Therapeutics, Inc.	Cell penetrating peptides and methods of making and using thereof
CA2949705A1 (en)	2014-05-21	2015-11-26	Cycloporters, Inc.	Cell penetrating peptides and methods of making and using thereof
US10456443B2 (en)	2014-08-27	2019-10-29	Ohio State Innovation Foundation	Peptidyl calcineurin inhibitors
CN107614004B (zh) *	2015-03-23	2022-12-06	激流生物科学有限公司	抗微生物肽及其使用方法
KR101692992B1 (ko)	2015-05-20	2017-01-17	연세대학교 산학협력단	고리형 펩타이드의 사전 활성화 합성방법 및 이에 따라 합성된 고리형 펩타이드
CA3078504A1 (en)	2017-10-04	2019-04-11	Ohio State Innovation Foundation	Bicyclic peptidyl inhibitors
WO2019148194A2 (en)	2018-01-29	2019-08-01	Ohio State Innovation Foundation	Peptidyl inhibitors of calcineurin-nfat interaction
WO2019165183A1 (en)	2018-02-22	2019-08-29	Entrada Therapeutics, Inc.	Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
EP3790890A4 (en)	2018-05-09	2022-03-02	Ohio State Innovation Foundation	CYCLIC PEPTIDES OF CELL PENETRATION WITH ONE OR MORE HYDROPHOBIC RESIDUES
GB202010268D0 (en) *	2020-07-03	2020-08-19	Novabiotics Ltd	Nail formulations and treatment regimes
CN115716865B (zh) *	2022-11-24	2024-04-30	安徽农业大学	具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-苏-酪-缬-亮肽及制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4051842A (en)	1975-09-15	1977-10-04	International Medical Corporation	Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de)	1976-06-11	1980-01-31	Siemens Ag, 1000 Berlin Und 8000 Muenchen	Implantierbare Dosiereinrichtung
US4383529A (en)	1980-11-03	1983-05-17	Wescor, Inc.	Iontophoretic electrode device, method and gel insert
US4962091A (en)	1986-05-23	1990-10-09	Syntex (U.S.A.) Inc.	Controlled release of macromolecular polypeptides
US5652211A (en) *	1991-02-11	1997-07-29	Biosynth S.R.L.	Peptides for neutralizing the toxicity of Lipid A
CA2145093C (en)	1992-09-25	2007-04-10	Lawrence Leroy Kunz	Therapeutic inhibitor of vascular smooth muscle cells
CA2227292A1 (en) *	1995-07-20	1997-02-06	Xoma Corporation	Anti-fungal peptides
DE19534177A1 (de) *	1995-09-15	1997-03-20	Merck Patent Gmbh	Cyclische Adhäsionsinhibitoren
US5916872A (en) *	1996-07-24	1999-06-29	Intrabiotics Pharmaceuticals, Inc.	Cyclic peptides having broad spectrum antimicrobial activity
US6096707A (en) *	1997-07-11	2000-08-01	Biotie Therapies Ltd.	Integrin binding peptide and use thereof
US6951652B2 (en) *	1998-07-29	2005-10-04	Biosynth S.R.L.	Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases
BR0209434A (pt) *	2001-05-04	2006-02-07	Scripps Research Inst	Peptìdeos antimicrobianos e composições
US7033991B2 (en) *	2001-07-16	2006-04-25	Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College	Inhibiting furin with polybasic peptides
WO2003093300A2 (en) *	2002-05-06	2003-11-13	The Scripps Research Institute	Anti-microbial peptides and compositions
WO2004050685A2 (en) *	2002-11-29	2004-06-17	Adaptive Therapeutics, Inc.	Antifungal therapeutic agents
US6783677B1 (en) *	2003-02-06	2004-08-31	Mayyar Systems, Inc.	Anaerobic film biogas digester system
AU2004246909B2 (en) *	2003-06-19	2010-08-19	Yeda Research & Development Co. Ltd.	Antimicrobial and anticancer lipopeptides
DK1927597T3 (en) *	2004-08-18	2017-02-13	Novabiotics Ltd	ANTIBACTERIAL PEPTIDES
NO346186B1 (no) *	2005-12-22	2022-04-11	Novabiotics Ltd	Anvendelse av et syklisk peptid for fremstilling av et medikament for behandling eller forebyggelse av en soppinfeksjon.

2006
- 2006-12-21 NO NO20083245A patent/NO346186B1/no unknown
- 2006-12-21 EP EP06842187A patent/EP1976863B1/en active Active
- 2006-12-21 EP EP11001659A patent/EP2357191A3/en not_active Withdrawn
- 2006-12-21 EP EP11001654A patent/EP2348039A3/en not_active Withdrawn
- 2006-12-21 JP JP2008546630A patent/JP5559477B2/ja active Active
- 2006-12-21 WO PCT/GB2006/004890 patent/WO2007072037A1/en active Application Filing
- 2006-12-21 US US12/158,945 patent/US8324154B2/en active Active
- 2006-12-21 MX MX2008008291A patent/MX2008008291A/es active IP Right Grant
- 2006-12-21 AU AU2006327973A patent/AU2006327973B2/en active Active
- 2006-12-21 CA CA2655448A patent/CA2655448C/en active Active
- 2006-12-21 EP EP11001658A patent/EP2357190A3/en not_active Withdrawn
- 2006-12-21 PL PL06842187T patent/PL1976863T3/pl unknown
- 2006-12-21 RU RU2008129866/04A patent/RU2463308C2/ru active
- 2006-12-21 KR KR1020087017946A patent/KR101413746B1/ko active Active
2008
- 2008-06-22 IL IL192373A patent/IL192373A/en active IP Right Grant
- 2008-07-21 ZA ZA2008/06329A patent/ZA200806329B/en unknown
- 2008-11-24 HK HK08112867.7A patent/HK1121462A1/xx unknown
2012
- 2012-08-22 US US13/592,246 patent/US8785375B2/en active Active
- 2012-11-16 JP JP2012252220A patent/JP6050096B2/ja not_active Expired - Fee Related
2013
- 2013-02-13 CY CY20131100131T patent/CY1113770T1/el unknown
2014
- 2014-04-25 JP JP2014090998A patent/JP6199797B2/ja active Active
2015
- 2015-08-20 IL IL240686A patent/IL240686A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP2348039A3 (en)	2011-08-24
JP2014167010A (ja)	2014-09-11
JP6050096B2 (ja)	2016-12-21
WO2007072037A1 (en)	2007-06-28
KR20080081062A (ko)	2008-09-05
US20120316103A1 (en)	2012-12-13
IL240686A (en)	2017-07-31
MX2008008291A (es)	2008-09-03
WO2007072037A9 (en)	2009-03-05
EP2357190A3 (en)	2011-08-24
JP6199797B2 (ja)	2017-09-20
CA2655448C (en)	2016-09-06
NO20083245L (no)	2008-09-12
AU2006327973A1 (en)	2007-06-28
EP1976863A1 (en)	2008-10-08
AU2006327973B2 (en)	2012-04-12
IL192373A (en)	2015-09-24
NO346186B1 (no)	2022-04-11
JP2013047268A (ja)	2013-03-07
JP2009520794A (ja)	2009-05-28
EP2357190A2 (en)	2011-08-17
EP2348039A2 (en)	2011-07-27
RU2008129866A (ru)	2010-01-27
EP2357191A3 (en)	2011-08-24
RU2463308C2 (ru)	2012-10-10
EP1976863B1 (en)	2012-12-12
JP5559477B2 (ja)	2014-07-23
ZA200806329B (en)	2009-12-30
CA2655448A1 (en)	2007-06-28
IL240686A0 (en)	2015-10-29
CY1113770T1 (el)	2016-07-27
US8324154B2 (en)	2012-12-04
HK1121462A1 (en)	2009-04-24
US8785375B2 (en)	2014-07-22
KR101413746B1 (ko)	2014-07-01
EP2357191A2 (en)	2011-08-17
IL192373A0 (en)	2008-12-29
US20090023641A1 (en)	2009-01-22

Publication	Publication Date	Title
IL240686A0 (en)	2015-10-29	Antimicrobial cyclic peptides
HK1221230A1 (zh)	2017-05-26	新型肽化合物
EP1824976A4 (en)	2008-07-09	ANTIMICROBIAL PEPTIDES
IL199835A0 (en)	2010-04-15	Novel antimicrobial peptides
TWI370113B (en)	2012-08-11	Insecticidal 3-acylaminobenzanilides
IL184428A0 (en)	2007-10-31	Peptides with neuropeptide-2-receptor
HK1131789A1 (en)	2010-02-05	Improved antimicrobial peptides
HK1114777A1 (en)	2008-11-14	Novel antimicrobial peptides
IL190286A0 (en)	2011-08-01	New cyclic peptide compounds
GB0516703D0 (en)	2005-09-21	Novel insecticides
IL185899A0 (en)	2008-12-29	Antibacterial amide-macrocycles v
GB0508863D0 (en)	2005-06-08	Peptide
ZA200802571B (en)	2009-03-25	GDNF derived peptides
HK1170749A1 (en)	2013-03-08	Peptidic compounds
SG10201403126RA (en)	2014-10-30	Cyclic antimicrobial peptides
GB0526019D0 (en)	2006-02-01	Peptides
GB0509638D0 (en)	2005-06-15	Reflectron
GB0516527D0 (en)	2005-09-21	Peptides
GB0507989D0 (en)	2005-05-25	Novel insecticides
IL180491A0 (en)	2007-06-03	Cyclic peptides
GB0512969D0 (en)	2005-08-03	Peptides
GB0523953D0 (en)	2006-01-04	Peptides
GB0516303D0 (en)	2005-09-14	Peptide
ZA200709294B (en)	2009-01-28	Peptide
AU3686P (en)	2009-01-07	DOW30 Acmena smithii